glp 1 agonist black box warning Tirzepatide injection (Zepbound®): Basic information for prescribers Pharmacovigilance Assessment of Compounded GLP-1

Conclusion The story of GLP-1 medications is rapidly evolving

Patients on GLP-1 receptor agonists may have altered gastrointestinal motility, theoretically increasing the risk of aspiration during anesthesia

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

GLP-1 receptors in your hypothalamus and other brain regions control appetite and satiety

Muscle pain (myalgia) is not listed as a common adverse effect in the FDA-approved prescribing information for most GLP-1 receptor agonists

doi:10.1002/cpt.2430 7